www.StockMarketingInc.com: Welcome To Stock Marketing Inc. Check Us Out!! Strong Alerts!! XDSL,STTN,GNXP,HFBG,ISCO,NNVC:: Sign Up Today

• Published in: M2 Presswire
• Format: Newsletter
• Language: English
• Published: Coventry Normans Media Ltd 21.07.2010
• Subjects: Automation; Beverages; Bulletin boards; Design; Drilling; Gold; Marketing; Nanotechnology; R&D; Research & development; Technology; Workforce planning

Chief Geologist John Hiner said, "We're extremely pleased to report our Class 3 permit approval, which allows us to begin trenching and drilling operations. We're well prepared for this development. Our camp is fully established and our drill and trenching equipment are currently onsite. We will begin construction of drill pads immediately and the mobilization of our drilling crew. We expect to complete both steps within the next few days and be drilling by week's end." Mr. Hiner continued, "Over the last couple of weeks, we've completed an accurate differential GPS survey and utilized the survey data to locate all known previous trenches, historic drill holes, and other data pertinent to mineralization on the property. The data have been compiled and assembled in our GIS database and the work we've completed on site, which entailed accurate re-location of trench and drill hole data, has allowed us to accurately define the location of previously delineated mineralized zones." Mr. Hiner concluded, "Based on our work to date, we have established several gold and silver drill targets and have mapped the exact coordinates for additional trenching and our initial drill program. Trenching is planned to confirm and extend mineralized zones. Confirmation and step out drill holes have also been planned and staked and we'll initiate drilling once our crew is deployed onsite." About Guinness Exploration Guinness Exploration Inc. trades on the OTC-BB under the symbol GNXP. The Company was incorporated in Nevada in 2005 and incorporated its subsidiary Nantawa Resources Inc. in Yukon, Canada in 2009. In November, 2009, Guinness entered an agreement to acquire mineral claims for the Mount Nansen and the Tawa gold and silver exploration properties (collectively the 'Nantawa Project') in the Yukon and is now developing an exploration program. The Nantawa Project is situated in the prolific Tintina Gold Belt, a 1,200 km long area extending from northern British Columbia, through the Yukon Territory and into southwest Alaska. The Tintina Gold Belt includes such world-class, multi-million ounce gold deposits as Pogo, Fort Knox, True North, and Donlin Creek. The Nantawa Project claims consist of 203 full or fractional claims with a total area of 3,136.43 square hectares located in the South Central part of the Yukon, 180 km Northwest of Whitehorse and 60 km west of the Village of Carmacks. A complete independent geological report received by Guinness, dated November 27, 2009, can be viewed on Guinness' website: www.guinnessexploration.com. According to Dr. Jayaraman Packirisamy, Executive Director of IBVI, "ISCO offers our investors as well as corporate and academic partners a unique combination of Lifeline marketed research products with near-term revenue potential in India, CytoCor with potential to change standard of care for the widespread corneal blindness and vision impairment in India and the rest of Asia, and an opportunity to apply our well-educated work force and industrial grade facilities to develop and manufacture these and other biomedical products cost-efficiently in India. We therefore look much forward to lead the funding and implementation of ISCO India." Dr. Gopal Pande, managing scientist at The Centre for Cellular and Molecular Biology adds, "Our institution is a leader in cell biology in India and, while we have been involved with a wide range of opportunities in this field, we believe CytoCor represents a rare opportunity to produce functional, live human tissue from individual cells. We are keen to explore the possibilities with ISCO and IBVI and hope to not only apply our scientific expertise but also to host ISCO in India's first, state-of-the art, $60M, integrated research and clinical development facility for stem cells and regenerative medicine, CRF, established in collaboration between the CCMB and the Nizam's Institute of Medical Sciences." Under the letter of intent, IBVI will lead the funding and establishment of ISCO India with facilities and staff. ISCO will train Indian scientists and commercial staff and provide rights to the company's technologies, products and intellectual property as needed. ISCO India will be managed by a combined team of experienced development and business executives from IBVI and Sristi Biosciences in India and senior executives of ISCO in the US. ISCO India will be based in Hyderabad and continue to work closely with the leading team of ophthalmology scientists and clinicians at Sankara Nethralaya in Chennai as well as researchers and government bodies across India. Formal details of this arrangement are expected to become the subject of a definitive agreement in the near future.